G. Pugnet

Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2)

Pierre Charles, Benjamin Terrier, Élodie Perrodeau et al. · Annals of the Rheumatic Diseases · 2018 · 325 citations

COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study

Jérôme Avouac, Élodie Drumez, É. Hachulla et al. · The Lancet Rheumatology · 2021 · 290 citations · Full text

Rheumatoid Disorder, Rheumatology, Autoimmune Disease +9

Management of giant cell arteritis: Recommendations of the French Study Group for Large Vessel Vasculitis (GEFA)

Boris Bienvenu, K.H. Ly, M. Lambert et al. · La Revue de Médecine Interne · 2016 · 190 citations

Rheumatology, Glomerulonephritis, Vasculitis +7

Long-Term Rituximab Use to Maintain Remission of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

Pierre Charles, Élodie Perrodeau, M. Samson et al. · Annals of Internal Medicine · 2020 · 182 citations

Infliximab Versus Adalimumab in the Treatment of Refractory Inflammatory Uveitis: A Multicenter Study From the French Uveitis Network

Hélène Vallet, P. Sève, Lucie Biard et al. · Arthritis & Rheumatology · 2016 · 170 citations · Full text